BOOKMARK
  • Korean|
  • Chinese|
  • Japanese|
  • Vietnamese
본문내용 바로가기

Aju Business Daily

SEARCH
  • ECONOMY
  • ENTERTAINMENT
  • IT
  • South Korea
  • North Korea
  • WORLD
  • SPORTS
  • LIFESTYLE
  • AUTO MOTIVE
  • OPINION
  • PEOPLE
  • MILITARY
Home > Health > article

Seoul hospital to conduct clinical trial for Inovio's COVID-19 DNA vaccine candidate

Lim Chang-won Reporter(cwlim34@ajunews.com) | Posted : June 4, 2020, 15:05 | Updated : June 4, 2020, 15:05
  • 트위터
  • 페이스북
  • 웨이보

[Gettyimages Bank]

SEOUL -- The safety and efficacy of IN0-4800, a COVID-19 DNA vaccine candidate developed by Inovio Pharmaceuticals, an American biotechnology company, will be checked in clinical trials by a prominent state hospital in South Korea. Clinical trials will begin this month.

The International Vaccine Institute (IVI) won approval from the Ministry of Food and Drug Safety, a public health watchdog, for Phase 1 and 2 trials in South Korea. Under a contract with the institute, INO-4800 will be administered to 40 adults to verify safety. Seoul National University Hospital will acquire immune response data in an experiment on 120 people.

Inovio has promoted INO-4800 as a promising COVID-19 vaccine candidate. The company has assembled a global coalition of collaborators, partners and funders to rapidly advance INO-4800.

IVI's deal with Seoul National University Hospital came a day after South Korea unveiled a road map to develop plasma treatment by the year's end as well as antibody treatment and vaccines next year through active clinical research.

  • Lim Chang-won Reporter
  • email : cwlim34@ajunews.com
© Aju Business Daily & www.ajunews.com Copyright: All materials on this site may not be reproduced, distributed, transmitted, displayed, published or broadcast without the authorization from the Aju News Corporation.
  • twitter
  • facebook
  • weibo
  • link copy
  • LIST
  • TOP

Related news

  • .LG Chem secures $80 mln deal to supply poliovirus vaccine thru UNICEF.
    LG Chem secures $80 mln deal to supply poliovirus vaccine th…
  • .Moon visits announces potential deal with Novavax for 20 mln people: Yonhap.
    Moon visits announces potential deal with Novavax for 20 mln…
  • .Samsung supports smart production of COVID-19 vaccine syringes.
    Samsung supports smart production of COVID-19 vaccine syring…
  • .S. Korean regulators start review on AstraZeneca vaccine for quick use in February .
    S. Korean regulators start review on AstraZeneca vaccine for…
  • .SK Bioscience embarks on clinical test of COVID-19 vaccine candidate NBP2001 .
    SK Bioscience embarks on clinical test of COVID-19 vaccine c…

Real Time Photo News

  • .Singer HyunA to end 14-month hiatus with mini-album Im Not Cool.

    Singer HyunA to end 14-month hiatus with mini-album 'I'm Not Cool'

  • .NCSofts global K-pop fan community platform to service original content including songs.

    NCSoft's global K-pop fan community platform to service original content including songs

  • .Singer IU drops teaser image for upcoming full album.

    Singer IU drops teaser image for upcoming full album

  • .Cube Entertainment partners with web comics company to create online video content.

    Cube Entertainment partners with web comics company to create online video content

  • .Sci-fi film starring Song Joong-ki to be reelased on Netflix in February.

    Sci-fi film starring Song Joong-ki to be reelased on Netflix in February

Latest News

more+

  • LA-bound Maersk containership loses some 750 containers overboard in Pacific
  • SK Bioscience selected to manage COVID-19 vaccine distribution in S. Korea
  • S. Korea finalizes official process of imposing 513% tariff on imported rice
  • Verizon becomes first to deploy Samsung's fully virtualized 5G solutions
  • Singer HyunA to end 14-month hiatus with mini-album 'I'm Not Cool'
Aju Business Daily
  • ABOUT US
  • CONTACT US
  • PRIVACY STATEMENT
  • Copyright Policy

Address : Aju News Corporation LEEMA Building, 11th floor, 42, Jong-ro 1-gil, Jongno-gu, Seoul.    Mail : swatchsjp@ajunews.com

Copyright ⓒ 2016 By Ajunews Corporation, All Rights Reserved.

Mobile view